Last update Jan. 24, 2017
Very Low Risk
Topically used as a 0.2% cream or ointment for the treatment of wounds, ulcers, skin infections and burns.
At latest update relevant published data on its excretion into breast milk were not found.
It is not absorbed in significant amounts into the systemic circulation, even when applied on burned surfaces (AEMPS 2007).
The small dose used and low plasma uptake of most topical dermatological preparations make it unlikely that significant amounts would pass into breastmilk.
Do not apply on the breast to prevent the infant from taking it; if necessary, do it after a feeding and clean it up thoroughly with water before the next one. It is toxic when taken by mouth, may cause contact dermatitis and hemolysis in cases of glucose-6-phosphate dehydrogenase deficiency (AEMPS 2007).
We do not have alternatives for Нитрофурал since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM